nonresectable pancreatic head cancer
Conditions
Interventions
When a tumor mass is detected based on diagnostic imaging including US and CT, and tumor-related obstructive jaundice is suspected, we determine whether it is pancreas cancer or not by endoscopic panc
Sponsors
Faculty of Medicine, University of Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with unresectable pancreatic head cancer causing stricture of the bile duct Patients with stricture in mid or lower bile duct Patients with cancer radically unresectable, Patients who will not able to endure surgery. Patients refusing to undergo surgery Patients with cancer>=stage 3 of TNM classification of UICC Patients who fully understand and are willing to give a written informed consent about participation.
Exclusion criteria
Exclusion criteria: Patients with cancer endoscopically accessible Patients with cancer endoscopically accessible Patients with performance status 4 (See Appendix) Patients with severe complications on other organs (>=stage 3 of ASA classification) except dialysis patients Patients without an informed consent Patients determined as not eligible by doctors in charge. Patients with intraductal papillary-mucinous tumor:(IPMT)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stent patency and occulusion rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Survival, Cost effectiveness, Types and frequency of complications | — |
Countries
Japan
Contacts
Public ContactHiromitsu Isayama
Faculty of Medicine, University of Tokyo Department of Gastroenterology
Outcome results
None listed